Barclays
ETON icon

Barclays’s Eton Pharmaceutcials ETON Stock Holding History

Barclays’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$811K Sell
15,746
-40,435
-72% -$2.05M ﹤0.01% 3190
2026
Q2 		$2.03M Buy
56,181
+6,807
+14% +$200K ﹤0.01% 2328
2026
Q1 		$1.22M Sell
49,374
-2,074
-4% -$36.3K ﹤0.01% 2631
2025
Q4 		$870K Buy
51,448
+14,642
+40% +$258K ﹤0.01% 3536
2025
Q3 		$800K Sell
36,806
-8,984
-20% -$149K ﹤0.01% 3507
2025
Q2 		$653K Buy
45,790
+1,129
+3% +$17.8K ﹤0.01% 3610
2025
Q1 		$580K Sell
44,661
-10,225
-19% -$154K ﹤0.01% 3438
2024
Q4 		$731K Buy
+54,886
New +$557K ﹤0.01% 3589
2021
Q4 		– Sell
-2,137
Closed -$11K – 4271
2021
Q3 		$11K Sell
2,137
-1,853
-46% -$9.6K ﹤0.01% 4500
2021
Q2 		$25K Sell
3,990
-10,288
-72% -$76.2K ﹤0.01% 4422
2021
Q1 		$104K Buy
14,278
+8,767
+159% +$74.8K ﹤0.01% 3985
2020
Q4 		$45K Sell
5,511
-1,209
-18% -$9.33K ﹤0.01% 4449
2020
Q3 		$53K Sell
6,720
-1,344
-17% -$9.18K ﹤0.01% 4569
2020
Q2 		$45K Buy
+8,064
New +$40K ﹤0.01% 4968
2019
Q2 		– Sell
-8,800
Closed -$70K – 7014
2019
Q1 		$70K Buy
+8,800
New +$61.1K ﹤0.01% 5637

Other funds holding ETON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Westside Investment Management
Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Thompson Siegel & Walmsley
Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Barclays's ETON Position: Q3 2026 in Review

Barclays reduced its Eton Pharmaceutcials (ETON) stake by 72% in Q3 2026, selling an estimated $2.05M and leaving 15,746 shares worth $811K. The position accounts for ﹤0.01% of the portfolio, ranked #3190.

Barclays first reported a position in ETON in Q1 2019 and has held it in 15 quarters since. The position peaked at $2.03M in Q2 2026. 104 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

  • Barclays held 15,746 shares of Eton Pharmaceutcials worth $811K as of Q3 2026.
  • Barclays sold 40,435 Eton Pharmaceutcials shares in Q3 2026, an estimated $2.05M.
  • Eton Pharmaceutcials made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3190 holding.
  • Barclays first reported a position in Eton Pharmaceutcials in Q1 2019 and has held it in 15 quarters since.
  • Barclays's Eton Pharmaceutcials position peaked at $2.03M in Q2 2026.
  • 104 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.